Sector Update: Health Care Stocks Edge Higher in Late Afternoon

MT Newswires Live08-28

Health care stocks edged higher late Tuesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.1%.

The iShares Biotechnology ETF (IBB) eased 0.1%.

In corporate news, Cosciens Biopharma (CSCI) shares plunged 32% after the company said top-line results from a phase 3 trial assessing macimorelin to diagnose Childhood Onset Growth Hormone Deficiency showed the study didn't meet its primary efficacy endpoint.

Trinity Biotech (TRIB) shares jumped 22%, a day after the company received substantial additional orders for TrinScreen HIV, leading to an increase in its 2024 sales revenue outlook for the product to $10 million from $8 million.

Insulet (PODD) shares jumped 6.3% after the company said the US Food and Drug Administration approved its Omnipod 5 automated insulin delivery system for adults with type 2 diabetes.

Eli Lilly (LLY) launched a new, cheaper version of its weight-loss drug Zepbound to expand the product's access and meet high demand. The shares added 0.2%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment